Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenkun Ma

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Cancer Letters|April 1, 2019
Activation of PSGR with β-ionone suppresses prostate cancer progression by blocking androgen receptor nuclear translocationHongjun Xie, Tianjie Liu, Jiaqi Chen, et al.
Journal of Medicinal Chemistry|November 13, 2010
Synthesis and structure-activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Iveta Kmentova, Hamish S Sutherland, Brian D Palmer, et al.
Journal of Medicinal Chemistry|March 18, 2015
Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Brian D Palmer, Hamish S Sutherland, Adrian Blaser, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniaeHong Yong, Yu Gui Gu, Richard F Clark, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Synthesis and antibacterial evaluation of a novel series of rifabutin-like spirorifamycinsIn Ho Kim, Keith D Combrink, Zhenkun Ma, et al.
Molecules (Basel, Switzerland)|April 12, 2014
Synthesis and biological evaluation of novel 2-methoxypyridylamino-substituted riminophenazine derivatives as antituberculosis agentsDongfeng Zhang, Yang Liu, Chunlin Zhang, et al.
Journal of Medicinal Chemistry|December 9, 2009
Synthesis and structure-activity relationships of antitubercular 2-nitroimidazooxazines bearing heterocyclic side chainsHamish S Sutherland, Adrian Blaser, Iveta Kmentova, et al.
Journal of Medicinal Chemistry|August 18, 2011
Synthesis and structure-activity relationships of varied ether linker analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5h-imidazo[2,1-b][1,3]oxazine (PA-824)Andrew M Thompson, Hamish S Sutherland, Brian D Palmer, et al.
Journal of Medicinal Chemistry|December 14, 2011
Structure-activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Adrian Blaser, Brian D Palmer, Hamish S Sutherland, et al.
Journal of Medicinal Chemistry|November 26, 2009
Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Brian D Palmer, Andrew M Thompson, Hamish S Sutherland, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Cancer Letters|April 1, 2019
Activation of PSGR with β-ionone suppresses prostate cancer progression by blocking androgen receptor nuclear translocationHongjun Xie, Tianjie Liu, Jiaqi Chen, et al.
Journal of Medicinal Chemistry|November 13, 2010
Synthesis and structure-activity relationships of aza- and diazabiphenyl analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Iveta Kmentova, Hamish S Sutherland, Brian D Palmer, et al.
Journal of Medicinal Chemistry|March 18, 2015
Synthesis and structure-activity relationships for extended side chain analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Brian D Palmer, Hamish S Sutherland, Adrian Blaser, et al.
Bioorganic & Medicinal Chemistry Letters|May 3, 2005
Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniaeHong Yong, Yu Gui Gu, Richard F Clark, et al.
Bioorganic & Medicinal Chemistry Letters|December 27, 2006
Synthesis and antibacterial evaluation of a novel series of rifabutin-like spirorifamycinsIn Ho Kim, Keith D Combrink, Zhenkun Ma, et al.
Molecules (Basel, Switzerland)|April 12, 2014
Synthesis and biological evaluation of novel 2-methoxypyridylamino-substituted riminophenazine derivatives as antituberculosis agentsDongfeng Zhang, Yang Liu, Chunlin Zhang, et al.
Journal of Medicinal Chemistry|December 9, 2009
Synthesis and structure-activity relationships of antitubercular 2-nitroimidazooxazines bearing heterocyclic side chainsHamish S Sutherland, Adrian Blaser, Iveta Kmentova, et al.
Journal of Medicinal Chemistry|August 18, 2011
Synthesis and structure-activity relationships of varied ether linker analogues of the antitubercular drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5h-imidazo[2,1-b][1,3]oxazine (PA-824)Andrew M Thompson, Hamish S Sutherland, Brian D Palmer, et al.
Journal of Medicinal Chemistry|December 14, 2011
Structure-activity relationships for amide-, carbamate-, and urea-linked analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Adrian Blaser, Brian D Palmer, Hamish S Sutherland, et al.
Journal of Medicinal Chemistry|November 26, 2009
Synthesis and structure-activity studies of biphenyl analogues of the tuberculosis drug (6S)-2-nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)Brian D Palmer, Andrew M Thompson, Hamish S Sutherland, et al.
Pageof 7